Logo image of 1AFX.MI

CARL ZEISS MEDITEC AG - BR (1AFX.MI) Stock Price, Forecast & Analysis

Europe - Euronext Milan - BIT:1AFX - DE0005313704 - Common Stock

28.88 EUR
+0.24 (+0.84%)
Last: 1/26/2026, 7:00:00 PM

1AFX.MI Key Statistics, Chart & Performance

Key Statistics
Market Cap2.58B
Revenue(TTM)2.23B
Net Income(TTM)141.22M
Shares89.44M
Float34.64M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend0.6
Dividend Yield1.87%
EPS(TTM)1.61
PE17.94
Fwd PE14.9
Earnings (Next)02-10
IPO2000-03-20
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
1AFX.MI short term performance overview.The bars show the price performance of 1AFX.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

1AFX.MI long term performance overview.The bars show the price performance of 1AFX.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1AFX.MI is 28.88 EUR.

CARL ZEISS MEDITEC AG - BR / 1AFX Daily stock chart

1AFX.MI Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to 1AFX.MI.


Chartmill TA Rating
Chartmill Setup Rating

1AFX.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to 1AFX.MI. Both the profitability and the financial health of 1AFX.MI get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1AFX.MI Financial Highlights

Over the last trailing twelve months 1AFX.MI reported a non-GAAP Earnings per Share(EPS) of 1.61. The EPS decreased by -19.9% compared to the year before.


Industry RankSector Rank
PM (TTM) 6.34%
ROA 4.15%
ROE 6.67%
Debt/Equity 0.27
Chartmill High Growth Momentum
EPS Q2Q%-14.49%
Sales Q2Q%8.27%
EPS 1Y (TTM)-19.9%
Revenue 1Y (TTM)7.82%

1AFX.MI Forecast & Estimates

22 analysts have analysed 1AFX.MI and the average price target is 49.99 EUR. This implies a price increase of 73.11% is expected in the next year compared to the current price of 28.88.

For the next year, analysts expect an EPS growth of 20.35% and a revenue growth 4.23% for 1AFX.MI


Analysts
Analysts71.82
Price Target49.99 (73.1%)
EPS Next Y20.35%
Revenue Next Year4.23%

1AFX.MI Ownership

Ownership
Inst Owners25.21%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About 1AFX.MI

Company Profile

1AFX logo image Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.

Company Info

CARL ZEISS MEDITEC AG - BR

Goeschwitzer Strasse 51-52

Jena THUERINGEN DE

Employees: 5784

1AFX Company Website

1AFX Investor Relations

Phone: 493641220331

CARL ZEISS MEDITEC AG - BR / 1AFX.MI FAQ

What does CARL ZEISS MEDITEC AG - BR do?

Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.


What is the current price of 1AFX stock?

The current stock price of 1AFX.MI is 28.88 EUR. The price increased by 0.84% in the last trading session.


Does CARL ZEISS MEDITEC AG - BR pay dividends?

CARL ZEISS MEDITEC AG - BR (1AFX.MI) has a dividend yield of 1.87%. The yearly dividend amount is currently 0.6.


What is the ChartMill technical and fundamental rating of 1AFX stock?

1AFX.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the analyst forecast for 1AFX.MI stock?

22 analysts have analysed 1AFX.MI and the average price target is 49.99 EUR. This implies a price increase of 73.11% is expected in the next year compared to the current price of 28.88.


Is CARL ZEISS MEDITEC AG - BR (1AFX.MI) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1AFX.MI.


Can you provide the market cap for CARL ZEISS MEDITEC AG - BR?

CARL ZEISS MEDITEC AG - BR (1AFX.MI) has a market capitalization of 2.58B EUR. This makes 1AFX.MI a Mid Cap stock.